ARCHIVES

Tesetaxel Showed 20 Percent Response In Second-Line Therapy In Phase IIb Trial

This article is from The Cancer Letter archive.

Vol. 35 No. 1 | January 27, 2012

Download PDF Visit The Full Archive

Related Articles

US, Italy Plan Greater Scientific Collaboration

May 16, 2003

Federal Standards Improve Mammogram Quality, GAO Finds

November 17, 1995

Two Court Rulings Conflict In Paclitaxel Patent Battle.

January 18, 2002

Researchers Find Genetic Alterations in Triple-Negative Cancers Following Treatment

January 25, 2013

Phase II ThermoDox Trial Demonstrates Positive Response

August 29, 2014

Henderson Heads HHS Preparedness Office; NCI Awards $22M Southern Cohort Study.

November 9, 2001